Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine

▴ Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine
An MoU was signed on 5th Nov between the government of Bangladesh, Beximco Pharmaceutical Ltd and the Serum Institute of India for priority delivery of 3 crores COVID-19 vaccine doses.

The process of development of the vaccine is in the final stages at the University of Oxford and AstraZeneca.

Health Minister of Bangladesh Zahid Maleque and High Commissioner of India to Bangladesh Vikram Doraiswami were present on the occasion along with other senior officials of the Health Ministry of Bangladesh and the two companies.

Calling it a ‘landmark agreement’, Health Minister Zahid Maleque expressed the hope that the people of Bangladesh will get relief from this. He said that initially 1.5 crore people will be vaccinated as each person will require two doses of the vaccine.

High Commissioner Vikram Doraiswami said that the vaccine from India was chosen not only because it was the best price but also because it is most suitable for the conditions for the distribution of the vaccine in Bangladesh.

He said that the vaccine is also one of the most promising candidates which are being brought up to the international regulators. The High Commissioner said that it is the culmination of the agenda that Prime Minister Narendra Modi put forward in March this year when he told SAARC leaders that this battle should be fought together and won together.

Meanwhile, new air service between India and Bangladesh under the air-bubble arrangement started yesterday. Welcoming the start of the new service, Bangladesh State Minister for Civil Aviation Md. Mahbub Ali said that the air-bubble arrangement between the two countries has helped people who need to travel for medical, business, and other purposes. He pointed out that Bangladesh and India enjoyed excellent relations and Prime Minister Sheikh Hasina is working to further strengthen people to people ties between the two countries.

Tags : #Bangladesh #India #AstraZeneca #UniversityofOxford #PMNarendraModi #PMSeikhHasina #COVIDvaccine #LatestPharmaNews6thNov

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026